PSYCHOSOCIAL CORE

心理社会核心

基本信息

项目摘要

The Psychosocial Core conducts a comprehensive assessment of the primary caregivers of all subjects participating in the Clinical Core, and family members of those with MCI and AD, follows them longitudinally and provides them with counseling on request. The routine structured multifaceted assessment is in two parts: the first part includes measures of depression, anxiety, social network and support and quality of life; the second part measures family conflict, behavior problems and caregiver reaction, caregiver appraisal, formal and informal support utilization and other specific characteristics related to caregiving. Family members of patients with AD complete the entire assessment. Subjects with MCI, their study partners and cognitively normal subjects who are not caregivers complete only the first part of this assessment. At the conclusion of every diagnostic evaluation of the Clinical Core, counselors of the Psychosocial Core conduct conferences with the subject, primary caregiver (if appropriate) and other family members. The counseling staff is available to respond to requests for help and information, are a user-friendly resource and a link between center subjects and other center staff. They make regular follow-up telephone calls to all participants in the Psychosocial Core. Their activities facilitate recruitment of new subjects, retention of current subjects and participation of subjects in autopsy tracking and in research studies. The Psychosocial Core data is a resource for the research of the NYU Psychosocial Research Program, and for other collaborating investigators in the field. The Psychosocial Core includes a comprehensive genetic counseling and education program, which will serve the goals of the NIA-Genetics Initiative and ADCC-affiliated researchers in genetics and proteomics and provide data to extend our evaluations of psychosocial interventions to include development of effective counseling and support for concerned subjects and family members about genetic risk for AD. The large database and subject pool, to which we will continue to add new subjects and longitudinal information, will be a valuable research resource in its own right and foster the formulation of new research to improve caregiver and patient well-being.
心理社会核心对参与临床核心的所有受试者的主要照顾者以及MCI和AD患者的家庭成员进行全面评估,并对他们进行纵向跟踪,并根据要求为他们提供咨询。常规结构化的多方面评估分为两部分:第一部分包括抑郁、焦虑、社会网络和支持以及生活质量的测量;第二部分测量家庭冲突、行为问题和照顾者反应、照顾者评价、正式和非正式支持利用等与照顾相关的具体特征。AD患者的家庭成员完成整个评估。轻度认知障碍的受试者、他们的研究伙伴和认知正常的受试者(不是照顾者)只完成这项评估的第一部分。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Mary Sherman Mittelman其他文献

Mary Sherman Mittelman的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Mary Sherman Mittelman', 18)}}的其他基金

Research Education Core
研究教育核心
  • 批准号:
    10730062
  • 财政年份:
    2023
  • 资助金额:
    $ 14.28万
  • 项目类别:
Psychosocial Core
心理社会核心
  • 批准号:
    10643951
  • 财政年份:
    2020
  • 资助金额:
    $ 14.28万
  • 项目类别:
Psychosocial Core
心理社会核心
  • 批准号:
    10439586
  • 财政年份:
    2020
  • 资助金额:
    $ 14.28万
  • 项目类别:
Understanding the lived experience of couples across the trajectory of dementia
了解患痴呆症的夫妇的生活经历
  • 批准号:
    10434807
  • 财政年份:
    2019
  • 资助金额:
    $ 14.28万
  • 项目类别:
Understanding the lived experience of couples across the trajectory of dementia
了解患痴呆症的夫妇的生活经历
  • 批准号:
    10229555
  • 财政年份:
    2019
  • 资助金额:
    $ 14.28万
  • 项目类别:
Understanding the lived experience of couples across the trajectory of dementia
了解患痴呆症的夫妇的生活经历
  • 批准号:
    10015193
  • 财政年份:
    2019
  • 资助金额:
    $ 14.28万
  • 项目类别:
Understanding the lived experience of couples across the trajectory of dementia
了解患痴呆症的夫妇的生活经历
  • 批准号:
    10671893
  • 财政年份:
    2019
  • 资助金额:
    $ 14.28万
  • 项目类别:
Understanding the lived experience of couples across the trajectory of dementia
了解患痴呆症的夫妇的生活经历
  • 批准号:
    10683949
  • 财政年份:
    2019
  • 资助金额:
    $ 14.28万
  • 项目类别:
Understanding the lived experience of couples across the trajectory of dementia
了解患痴呆症的夫妇的生活经历
  • 批准号:
    10426630
  • 财政年份:
    2019
  • 资助金额:
    $ 14.28万
  • 项目类别:
Understanding the lived experience of couples across the trajectory of dementia
了解患痴呆症的夫妇的生活经历
  • 批准号:
    10270548
  • 财政年份:
    2019
  • 资助金额:
    $ 14.28万
  • 项目类别:

相似国自然基金

新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
  • 批准号:
    81000622
  • 批准年份:
    2010
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
  • 批准号:
    31060293
  • 批准年份:
    2010
  • 资助金额:
    26.0 万元
  • 项目类别:
    地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
  • 批准号:
    30960334
  • 批准年份:
    2009
  • 资助金额:
    22.0 万元
  • 项目类别:
    地区科学基金项目

相似海外基金

Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
  • 批准号:
    10657993
  • 财政年份:
    2023
  • 资助金额:
    $ 14.28万
  • 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
  • 批准号:
    10381163
  • 财政年份:
    2022
  • 资助金额:
    $ 14.28万
  • 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
  • 批准号:
    10531959
  • 财政年份:
    2022
  • 资助金额:
    $ 14.28万
  • 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
  • 批准号:
    10700991
  • 财政年份:
    2022
  • 资助金额:
    $ 14.28万
  • 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
  • 批准号:
    10518582
  • 财政年份:
    2022
  • 资助金额:
    $ 14.28万
  • 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
  • 批准号:
    10672973
  • 财政年份:
    2022
  • 资助金额:
    $ 14.28万
  • 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
  • 批准号:
    10585925
  • 财政年份:
    2022
  • 资助金额:
    $ 14.28万
  • 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
  • 批准号:
    10180000
  • 财政年份:
    2021
  • 资助金额:
    $ 14.28万
  • 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
  • 批准号:
    10049426
  • 财政年份:
    2021
  • 资助金额:
    $ 14.28万
  • 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
  • 批准号:
    10295809
  • 财政年份:
    2021
  • 资助金额:
    $ 14.28万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了